Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$64.4M |
| 2 |
DuPont de Nemours
DD
|
+$35.6M |
| 3 |
Alibaba
BABA
|
+$35.4M |
| 4 |
Apple
AAPL
|
+$34.3M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$28.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$88.3M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$46.6M |
| 3 |
NBIS
Nebius Group N.V.
NBIS
|
+$40.7M |
| 4 |
Comcast
CMCSA
|
+$38.1M |
| 5 |
PG&E
PCG
|
+$31.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.94% |
| 2 | Financials | 10.6% |
| 3 | Healthcare | 8.31% |
| 4 | Industrials | 7.75% |
| 5 | Consumer Discretionary | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Wingstop
WING
$3.17B
| $683K | 0.01% |
+4,997
| New | +$734K |
|
|
EBSB
852
DELISTED
Meridian Bancorp, Inc.
EBSB
| $683K | 0.01% |
65,982
+41,225
| +167% | +$467K |
|
853
International Paper
IP
$21.7B
| $682K | 0.01% |
+17,752
| New | +$627K |
|
854
Ingevity
NGVT
$2.36B
| $682K | 0.01% |
13,801
-38,449
| -74% | -$2.17M |
|
|
VER
855
DELISTED
VEREIT, Inc.
VER
| $682K | 0.01% |
+20,980
| New | +$691K |
|
856
Opko Health
OPK
$1.1B
| $681K | 0.01% |
184,669
+123,509
| +202% | +$521K |
|
|
CODX
857
CALL
Co-Diagnostics
CODX
$7.75M
| $680K | 0.01% |
+1,667
| New | +$856K |
|
858
Ralph Lauren
RL
$22.1B
| $679K | 0.01% |
+9,988
| New | +$712K |
|
859
GDS Holdings
GDS
$6.4B
| $678K | 0.01% |
+8,282
| New | +$663K |
|
860
International Bancshares
IBOC
$4.48B
| $677K | 0.01% |
25,997
+15,693
| +152% | +$479K |
|
861
Rocket Pharmaceuticals
RCKT
$384M
| $676K | 0.01% |
+29,569
| New | +$729K |
|
862
First Citizens BancShares
FCNCA
$24.8B
| $675K | 0.01% |
2,116
+520
| +33% | +$201K |
|
863
Cohen & Steers
CNS
$4.26B
| $673K | 0.01% |
12,066
-3,722
| -24% | -$230K |
|
864
Brighthouse Financial
BHF
$2.98B
| $672K | 0.01% |
24,960
-69,220
| -73% | -$2.01M |
|
865
Globant
GLOB
$1.71B
| $672K | 0.01% |
+3,752
| New | +$646K |
|
|
MNTV
866
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $672K | 0.01% |
30,388
+13,113
| +76% | +$305K |
|
|
SRNE
867
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $668K | 0.01% |
+59,886
| New | +$548K |
|
868
Builders FirstSource
BLDR
$7.65B
| $663K | 0.01% |
20,316
-16,230
| -44% | -$441K |
|
869
EXL Service
EXLS
$5.72B
| $662K | 0.01% |
+50,140
| New | +$643K |
|
870
Brunswick
BC
$5.25B
| $661K | 0.01% |
11,221
-2,894
| -21% | -$185K |
|
871
Allstate
ALL
$65.6B
| $659K | 0.01% |
6,995
-39,454
| -85% | -$3.68M |
|
|
GTM
872
ZoomInfo Technologies
GTM
$1.13B
| $656K | 0.01% |
15,265
-258,427
| -94% | -$10.1M |
|
873
Nomad Foods
NOMD
$1.7B
| $655K | 0.01% |
25,717
-10,961
| -30% | -$260K |
|
|
CS
874
DELISTED
Credit Suisse Group
CS
| $654K | 0.01% |
65,587
-42,775
| -39% | -$458K |
|
875
Harmony Biosciences
HRMY
$2.25B
| $653K | 0.01% |
+19,255
| New | +$702K |
|
Similar funds
Michael Gelband's Q3 2020 Portfolio in Review
As of Q3 2020, Michael Gelband held 2,471 positions worth $5.02B, up 30% from $3.85B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Michael Gelband deployed $816M of net new capital in Q3 2020, opening 743 new positions and adding to 409 existing holdings. Its largest new stake was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $46.6M trimmed.
- Michael Gelband's largest Q3 2020 buy was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.
- Michael Gelband added most to Charles Schwab in Q3 2020, an estimated $64.4M increase.
- Michael Gelband's biggest Q3 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $46.6M.
- Michael Gelband fully exited State Street SPDR S&P 500 ETF Trust in Q3 2020, selling an estimated $88.3M.
- Michael Gelband's ten largest holdings make up 32% of its $5.02B portfolio in Q3 2020.
- Michael Gelband opened 743 new positions and closed 789 in Q3 2020.
- Michael Gelband's portfolio value rose 30% quarter-over-quarter to $5.02B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.